Acción 7760 IMV CORPORATION
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas IMV Corporation

Acciones

7760

JP3100760002

Mercado cerrado - Japan Exchange
Otros sitios de cotización
 08:00:00 07/05/2024 		Varia. Cinco días. Varia. 1 de enero.
643 JPY +0,78 % Gráfico intradía de IMV Corporation +2,55 % +23,42 %
25/03 BioVaxys Technology planea una colocación privada; baja un 5,9 MT
2023 IMV Corporation (TSE:7760) anuncia una recompra de acciones por 400.000 acciones, que representan el 2,45% por 250 millones de yenes. CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Tranche Update on IMV Corporation's Equity Buyback Plan announced on November 21, 2023.
BioVaxys Technology Plans Private Placement; Down 5.9%
Biovaxys Completes The Acquisition Of All Intellectual Property And Clinical Stage Assets Of The Former IMV Inc.
BioVaxys Acquires Entire Technology Portfolio Of The Former IMV Inc.
Tranche Update on IMV Corporation's Equity Buyback Plan announced on November 21, 2023.
IMV Corporation announces an Equity Buyback for 400,000 shares, representing 2.45% for ¥250 million.
IMV Corporation authorizes a Buyback Plan.
IMV Corporation Reports Earnings Results for the Full Year Ended September 30, 2023
EKF Diagnostics hires CFO from Trellus Health, latter names successor
Trellus Health's Interim Finance Head Takes Full-time CFO Role at EKF Diagnostics
Imv Corporation Provides Dividend Guidance for the Fiscal Year Ending September 30, 2023
Imv Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2023
IMV Corporation Reports Earnings Results for the Half Year Ended March 31, 2023
IMV Receives Delisting Notice From Nasdaq Over Bankruptcy Proceedings in Canada
IMV Inc. Brief: Says Received NASDAQ Delisting Notice
IMV Inc. Brief: Says Received Nasdaq Notification Regarding Minimum Bid Price Deficiency
IMV Inc. Details Board Changes
IMV Inc. Brief: Hall Adds Co engaged Stonegate to explore strategic alternatives, "So that MVP-S can realize its full clinical potential"
IMV Inc. Brief: Andrew Hall, Chief Executive Officer, Said" "The market headwinds limiting available capital are, however, very real"
IMV Inc. Brief: Net loss and comprehensive loss of US$38.0 million ($4.55 per share) for Year ended December 31, 2022, Vs net loss and comprehensive loss of $36.6 ($4.93 per share) for Year ended December 31, 2021
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 7760
  4. Noticias IMV Corporation
  5. Otros idiomas